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256 The use of high energy milk formula for alimentary status
correction in children with cystic ﬁbrosis (CF)
E. Roslavtseva1, O. Simonova2, T. Borovik1, V. Sokolova2. 1Scientiﬁc Center for
Children Health, Nutrition, Moscow, Russian Federation; 2Scientiﬁc Center for
Children Health, Pulmonology, Moscow, Russian Federation
Objectives: Evaluation of tolerance and clinical efﬁcacy of nutritional support with
high energy milk formula in Russian young children with CF.
Methods: During the planned hospitalization (average 12.6 days) 30 children
aged 1.5−10 years old with CF and pancreatic insufﬁciency were given milk
formula (protein 4.2 g, fat 7.7 g, carbohydrates 16.39 g, energy 150 kcal/100ml,
enriched with ﬁber and prebiotic, vanilla taste) up to 200ml/day (1−3 years), 300ml
(4−6 years), 400ml (>6 years) between meals, with addition of 2500 IE (lipase) of
Creon to each 100ml of formula.
Results: Four (13.3%) children rejected. 26 (86.7%) of children accepted the
formula well, no allergic reactions, intolerance or stool worsening. 23 (88.5%)
patients gained weight by av. 415 g, with maximum gain of 2.3 kg in a boy who
received formula the longest (24 days). Skin fold thickness increased in 23 (88.5%)
children by average +0.364mm over triceps, in 17 (65.4%) by av. +0.372mm over
biceps, and upper arm muscle circumference increased in (84.6%) by av. +0.332 cm.
The daily Creon dose per 1 kg of body weight decreased in 11 (42.3%) cases because
of patient’s weight gain, and increased insigniﬁcantly in the rest.
Conclusions: The formula was well-tolerated and had an overall positive inﬂuence
on the nutritive status indices, despite of the short terms of application and fact
that Creon daily dose wasn’t signiﬁcantly increased. Thus, it can be used as the
additional feeding source in the most of young children with CF. However, taking
into account the cases of refusal and peculiarities of taste preferences, children with
CF require wider taste spectrum of products for additional feeding.
257 Improving nutrition for pediatric cystic ﬁbrosis patients
I. Ramirez1, A. Filbrun1, S.Z. Nasr1. 1University of Michigan, Department of
Pediatrics, Ann Arbor, United States
Objective: To improve the nutritional status of patients between 3 and 20 years
of age in our Cystic Fibrosis (CF) Center. We used median body mass index per-
centile (BMI%) as a marker of nutritional status, given that being 50th percentile
correlates with better pulmonary health. Our speciﬁc aim was to increase the BMI
of patients below the 25th percentile by 20 percent in one year.
Methods:
1. We reviewed our center’s CF Foundation patient registry data.
2. We chose to improve the nutritional status of our CF patients with BMI <25th
percentile as our primary outcome.
3. We instituted a standardized care plan and developed an algorithm.
Daily caloric needs and weight gain goals were calculated by our dietician and
discussed with the team, patients and families. Difﬁculty meeting weight gain goals
led to escalated nutritional support in a stepwise fashion starting with high-calorie
diet and oral supplements. That was followed by appetite stimulants, additional
social work and psychology intervention, frequent visits, and placement of G-tubes.
Data from October 2009 through December 2010 were reviewed.
Results: Baseline median BMI% for our center was 54 and remained stable over the
evaluation period. The median BMI% for those less than the 25th percentile at the
start of the study was 13.5. At the end of the evaluation period this increased to 18.9.
This is a 40 percent increase in median BMI% for this group of patients.
Conclusions: By teaming up with patients and families, standardizing care, provid-
ing a written plan with clear goals and developing and implementing a nutritional
care algorithm, we successfully improved nutritional outcomes in our highest risk
patients.
258 Does regaining birth weight Z score by 2 years of age impact on
clinical outcome in patients with cystic ﬁbrosis?
E.J. Pringle1, S. Ranganathan2,3,4, J. Harrison2,3,4, AREST-CF. 1University of
Aberdeen, School of Medicine, Aberdeen, United Kingdom; 2Royal Children’s
Hospital, Respiratory Medicine, Melbourne, Australia; 3Murdoch Children’s
Research Institute, Infection and Immunity, Melbourne, Australia; 4University of
Melbourne, Paediatrics, Melbourne, Australia
Background: Good nutrition in children with cystic ﬁbrosis (CF) is important
in maintaining lung function and respiratory health. Further research into early
nutrition of infants with CF may improve clinical outcomes during childhood.
Aims:
1. To determine the proportion of children recruited to the Australian Respiratory
Early Surveillance Team for Cystic Fibrosis (AREST-CF) programme who
regained their birth weight (BW) z score by 2 years old.
2. To compare characteristics and clinical outcomes of children who do and do not
regain BW z score by 2 years old.
Methods: A retrospective review of data collected annually by AREST-CF was
conducted. Data included clinical and nutritional status, lung function and struc-
ture, infection and inﬂammatory markers present in bronchoalveolar lavage ﬂuid.
Characteristics and clinical outcomes of infants who did and did not regain their
BW z score by the age of 2 years were compared.
Results: 72/99 (72.7%) children enrolled in AREST-CF were included in the
review (48 male), median age 4.95 years. 43 (59.7%) children successfully regained
BW z score by 2 years old and 29 (40.3%) of children failed to regain BW z score
by 2 years old. Children who regained their BW z score by the age of 2 years
had a lower BW z score at birth (p = 0.026). There were no other signiﬁcant dif-
ferences found. Furthermore, there were no differences found in clinical, infection,
inﬂammation and pulmonary function outcomes at 2, 3 or 5 years old.
Conclusion: Regaining BW z score by 2 years old may reﬂect lower BW rather
than improved clinical outcomes in later childhood in children with CF.
259 Nutrition and lung function in a tertiary cystic ﬁbrosis centre
N. Lagan1, A. Walsh1, L. Kelly1, M. Morgan1, F. Healy1, D. Slattery1. 1Children’s
University Hospital, Respiratory, Dublin, Ireland
Objectives:
1. To evaluate the nutritional status of children with cystic ﬁbrosis(CF) patients
attending our teritary service.
2. To compare nutrition with lung function. 3. To compare results with CF
Foundation Registry Report.
Method: A chart review was preformed on 86 patients with CF attending our centre.
Data collection included height, weight, BMI centiles, nutritional supplements, dose
of lipase iu per kg/day and if taking an acid blocker. Lung function was analysed
using forced expiratory volume in one second (FEV1) % predicted and forced vital
capacity. Mean and median FEV1 calculated using the three highest values over the
last one year, to prevent bias from pulmonary exacerbations. The patients had their
BMI calculated and plotted on centile charts for the average paediatric population.
Our 86 patients were categorised into 4 groups; <24months, 2−6years, 7−12 years,
and 13−17 years. Nutrition and lung function were assessed in the groups that could
perform the latter.
Results: Nutritional status in group <24 months (n = 8, 9.3%) demonstrated 75%
(n = 6) had a weight >50th centile. 2−6 years (n = 18, 21%) revealed 44% (n = 8)
had a weight >50th centile. In the 7−12 years group (n = 36, 42%) 58% (n = 21)
BMI >50th centile, and 13−17 yr age group (n = 24, 27%), 25%(n = 6) were
>50th centile and 16% (n = 4) were <9th centile. 6−12 years mean FEV1 97%,
median 98.3%. Those with a BMI <50th centile mean FEV1 and median was 89%,
88% respectively. 13−17 years mean FEV1 63.5% and median 74.6% and in those
with BMI <50th centile, mean FEV1 70% and median 60%.
Conclusion: Our results compare favourable with CFF Registry Report results.
